LAPATINIB
lapatinib 250 mg tablet, 70
LAPATINIB (9148L)
9148L
Manner of administration:Oral
Restriction
Indication: Metastatic (Stage IV) HER2 positive breast cancer
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 140 | # of repeats: 2 | DPMQ: $2,210.82 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tykerb | |||||